A phase I trial and PK study of cediranib (AZD2171), an...

Child's Nervous System 2015 / 9 Vol. 31; Iss. 9

A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors

Kieran, Mark W., Chi, Susan, Goldman, Stewart, Onar-Thomas, Arzu, Poussaint, Tina Young, Vajapeyam, Sridhar, Fahey, Frederic, Wu, Shengjie, Turner, David C., Stewart, Clinton F., Moses, Marsha, Packer
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Language:
english
Journal:
Child's Nervous System
DOI:
10.1007/s00381-015-2812-5
Date:
September, 2015
File:
PDF, 1.60 MB
english, 2015
Conversion to is in progress
Conversion to is failed